Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added; Melanoma and related topics (MedlinePlus Genetics) and Revision: v3.4.2 were removed.
    Difference
    0.2%
    Check dated 2026-03-12T14:32:44.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed as a related topic.
    Difference
    0.2%
    Check dated 2026-03-05T11:13:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed Melanoma and related topics (MedlinePlus Genetics) from the Related Topics section. This primarily affects navigation and context without changing the study details.
    Difference
    0.2%
    Check dated 2026-02-26T05:55:37.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Melanoma and related topics MedlinePlus Genetics were added, and the revision label was updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-11T23:42:32.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision added: v3.4.1. Melanoma and MedlinePlus Genetics were removed from related topics, along with the Revision: v3.4.0 entry.
    Difference
    0.2%
    Check dated 2026-02-04T22:58:57.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a glossary and related topic links (Melanoma and MedlinePlus Genetics) and updated revision metadata (Last Update Submitted that Met QC Criteria and Revision: v3.4.0). Removed older QC labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and the prior revision version (v3.3.4).
    Difference
    0.4%
    Check dated 2026-01-28T21:53:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.